Ginkgo Bioworks Share Price (NYSE: DNA)
$12.33
▲
0.28
(2.32%)
Live
Last updated on
Check the interactive Ginkgo Bioworks Stock chart to analyse performance
Ginkgo Bioworks stock performance
as on August 27, 2025 at 1:29 AM IST
- Today's Low:$12.16Today's High:$12.56
1.38%
Downside
Day's Volatility :3.18%
Upside
1.83%
- 52 Weeks Low:$5.0052 Weeks High:$16.85
59.45%
Downside
52 Weeks Volatility :70.33%
Upside
26.82%
Ginkgo Bioworks Stock Returns
Ginkgo Bioworks Holdings Inc Key Stats
Check Ginkgo Bioworks key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Ginkgo Bioworks Stock including INR - Dollar returns
The Ginkgo Bioworks stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ginkgo Bioworks investment value today
Current value as on today
₹1,60,999
Returns
₹60,999
(+61%)
Returns from Ginkgo Bioworks Stock
₹56,472 (+56.47%)
Dollar Returns*
₹4,527 (+4.53%)
Indian investors sentiment towards Ginkgo Bioworks Stock
Global Institutional Holdings in Ginkgo Bioworks Holdings Inc
Name
Holdings %
Viking Global Investors LP
6.04%
Baillie Gifford & Co Limited.
5.53%
Vanguard Group Inc
4.02%
Anchorage Advisors, LLC
2.95%
Erste Asset Management GmbH
2.79%
Legal & General Group PLC
2.52%
Analyst Recommendation on Ginkgo Bioworks Stock
Sell
7%Buy
42%Hold
50%Sell
Based on 14 Wall street analysts offering stock ratings for Ginkgo Bioworks(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Ginkgo Bioworks Share Price Target
What analysts predicted
Downside of 16.19%
Target:
$10.33
Current:
$12.33
Ginkgo Bioworks share price target is $10.33, a slight Downside of 16.19% compared to current price of $12.33 as per analysts' prediction.
Ginkgo Bioworks Stock Insights
Price Movement
In the last 3 months, DNA stock has moved up by 72.5%Increasing Revenue
Revenue is up for the last 3 quarters, 43.84M → 49.60M (in $), with an average increase of 5.9% per quarterIncreasing Net Profit
Netprofit is up for the last 3 quarters, -107.53M → -60.3M (in $), with an average increase of 34.5% per quarterDNA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.8% return, outperforming this stock by 11.8%DNA vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 110.3% return, outperforming this stock by 199.5%Price to Sales
ForDNA every $1 of sales, investors are willing to pay $2.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.3 for every $1 of sales.
Ginkgo Bioworks Holdings Inc Financials
Ginkgo Bioworks Technicals Summary
Sell
Neutral
Buy
Ginkgo Bioworks is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Ginkgo Bioworks Holdings Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -13.61% | 17.2% | 53.05% | -88.71% | 19.17% |
 | 2.56% | -20.81% | -52.23% | -3.35% | -6.84% |
 | 5.47% | 19.61% | 55.92% | 85.67% | 27.02% |
 | -15.59% | -19.02% | -19.41% | 38.13% | 41.78% |
 | 36.58% | 80.91% | 64.82% | 112.22% | 233.41% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -5.3 | -0.44 | -0.13 | NA | 11.06 |
| 14.86 | 14.86 | 1.21 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 28.08 | 28.08 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Sell | $743.0M | 19.17% | NA | -136.56% |
| Buy | $62.5B | -6.84% | 14.86 | 31.37% |
| NA | $38.3B | 27.02% | NA | -3.89% |
| Buy | $101.3B | 41.78% | 28.08 | 31.86% |
| Buy | $59.6B | 233.41% | NA | -12.96% |
Ginkgo Bioworks Dividend announcements
Ginkgo Bioworks Earnings
Ginkgo Bioworks’s price-to-earnings ratio stands at None
About Ginkgo Bioworks Holdings Inc
Key Management of Ginkgo Bioworks Holdings Inc
Important FAQs about investing in DNA Stock from India :
What is Ginkgo Bioworks share price today?
Ginkgo Bioworks share price today is $12.33 as on . Ginkgo Bioworks share today touched a day high of $12.56 and a low of $12.16.
What is the 52 week high and 52 week low for Ginkgo Bioworks share?
Ginkgo Bioworks share touched a 52 week high of $16.85 and a 52 week low of $5.00. Ginkgo Bioworks stock price today i.e. is trending at $12.33, lower by 26.82% versus the 52 week high.
How to invest in Ginkgo Bioworks Stock (DNA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Ginkgo Bioworks on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ginkgo Bioworks Shares that will get you 0.1217 shares as per Ginkgo Bioworks share price of $12.33 per share as on August 27, 2025 at 1:29 AM IST.
What is the minimum amount required to buy Ginkgo Bioworks Stock (DNA) from India?
Indian investors can start investing in Ginkgo Bioworks (DNA) shares with as little as ₹87.6525 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.53 in Ginkgo Bioworks stock (as per the Rupee-Dollar exchange rate as on August 26, 2025).
Based on Ginkgo Bioworks share’s latest price of $12.33 as on August 27, 2025 at 1:29 AM IST, you will get 0.8110 shares of Ginkgo Bioworks. Learn more about
fractional shares .
What are the returns that Ginkgo Bioworks has given to Indian investors in the last 5 years?
Ginkgo Bioworks stock has given 19.17% share price returns and 18.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Biogen Inc.$136.42
+0.04%
Viatris Inc.$10.48
-0.66%
Ge Healthcare Technologies Inc.$74.05
-0.72%
Fresenius Medical Care Ag$25.42
+0.51%
The Cigna Corp$299.03
-0.58%
United Therapeutics Corporation$306.41
+0.34%
Zimmer Biomet Holdings, Inc.$108.16
+0.78%
Edwards Lifesciences Corp.$80.94
+0.1%
Iqvia Holdings Inc.$188.44
+0.22%